Market Introduction
Protein expression is a process in which proteins are synthesized, modified and regulated. Protein expression involves laboratory techniques & procedures which aid in manufacture of proteins. The technique allows to produce and purify the desired protein, either inside or outside a cell. The proteins synthesized using protein expression technique can be used for industrial processes or to diagnose and to treat diseases.
Thus, the growing adoption of precision medicines are expected to create a significant demand for protein expression in the coming years, which is further anticipated to drive the protein expression market.
COVID-19 pandemic has become the most significant challenge in the region. This challenge will be especially frightening for the region’s fragile and conflict-torn states—such as Iraq, Sudan, Iran, Israel and Yemen as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable shortage of them. The Middle East countries have registered a growth in the number of COVID cases in the last few days. However, demand for protein expression systems in this pandemic is inclined from the outbreak of Covid-19, but now the pharma companies are working on developing strategies to develop and manufacture the required reagents, instruments for the research of vaccine fulfill the demands of protein expression. The demand of protein expression in the region is expected to increase due to the rising Covid-19 cases and other diseases such as cancer. The impact of the COVID19 pandemic on the regional protein expression market is moderate.
Market Overview and Dynamics
The Protein expression market in Middle East and Africa is expected to grow from US$ 106.0 million in 2021 to US$ 161.6 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The pharmaceutical and biotechnology industries have developed various techniques to treat cancer and neurodegenerative diseases. The transient gene expression technique has led to significant developments in the research related to neurotrauma and neurodegenerative diseases and introduced precision medicines for these conditions. Technological advancements in epigenetics, genetics, and proteomics support the development of therapeutics for the treatment of various genetic and rare genetic diseases caused by single and multiple cell disorders. Thus, the continuous research and development activities and growing government initiatives to support precision medicine boost the adoption of protein expression techniques.
Key Market Segments
In terms of product, the reagents segment accounted for the largest share of the Middle East and Africa protein expression market in 2020. In terms of services, the antibody development and production segment accounted for the largest share of the Middle East and Africa protein expression market in 2020. In terms of application, the therapeutic segment accounted for the largest share of the Middle East and Africa protein expression market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the Middle East and Africa protein expression market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the protein expression market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., GenScript, Merck KGaA, Takara Bio Inc., Bio-Rad Laboratories Inc., QIAGEN, New England Biolabs, and Promega Corporation.
Reasons to buy report
MIDDLE EAST AND AFRICA PROTEIN EXPRESSION MARKET SEGMENTATION
By Product
By Services
By Application
By End User
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 106.0 Million |
| Market Size by 2028 | US$ 161.6 Million |
| CAGR (2021 - 2028) | 6.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Protein Expression Market is valued at US$ 106.0 Million in 2021, it is projected to reach US$ 161.6 Million by 2028.
As per our report Middle East and Africa Protein Expression Market, the market size is valued at US$ 106.0 Million in 2021, projecting it to reach US$ 161.6 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.
The Middle East and Africa Protein Expression Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Protein Expression Market report:
The Middle East and Africa Protein Expression Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Protein Expression Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Protein Expression Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Protein Expression Market
